These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6423709)

  • 1. Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates.
    Burg G; Kerl H; Kaudewitz P; Braun-Falco O; Mason DY
    J Dermatol Surg Oncol; 1984 Apr; 10(4):284-90. PubMed ID: 6423709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas.
    Bayer-Garner IB; Prieto VG; Smoller BR
    Arch Pathol Lab Med; 2004 Jun; 128(6):645-8. PubMed ID: 15163236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated kappa and lambda light chain mRNA expression for the assessment of B-cell clonality in cutaneous B-cell infiltrates: its utility and diagnostic application.
    Magro C; Crowson AN; Porcu P; Nuovo GJ
    J Cutan Pathol; 2003 Sep; 30(8):504-11. PubMed ID: 12950502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraffin section light-chain immunostaining of large-cell lymphocytoma.
    Winkelmann RK; Banks PM
    Acta Derm Venereol; 1988; 68(4):356-8. PubMed ID: 2459884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambda light chain predominance as a sign of emerging lymphoma.
    Bray M; Alper MG
    Am J Clin Pathol; 1983 Oct; 80(4):526-8. PubMed ID: 6414286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular J chains in lymphoproliferative diseases.
    Kelényi G
    Virchows Arch A Pathol Anat Histopathol; 1985; 405(3):365-78. PubMed ID: 3919501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistological study of reactive lymphoid tissue.
    Morris HB; Mason DY; Stein H; Lennert K
    Histopathology; 1983 Nov; 7(6):809-23. PubMed ID: 6420310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathology of follicular lymphomas. A model of B-lymphocyte homing.
    Warnke R; Levy R
    N Engl J Med; 1978 Mar; 298(9):481-6. PubMed ID: 414136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The monoclonality of human B-cell lymphomas.
    Levy R; Warnke R; Dorfman RF; Haimovich J
    J Exp Med; 1977 Apr; 145(4):1014-28. PubMed ID: 404386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of numerical ratios for defining monoclonality of immunoglobulin light chains in B-cell lymphomas.
    Samoszuk MK; Krailo M; Yan QH; Lukes RJ; Parker JW
    Diagn Immunol; 1985; 3(3):133-8. PubMed ID: 3931957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Applications of the peroxidase-anti-peroxidase technique in dermatology (author's transl)].
    Rauch HJ; Kerl H; Kresbach H
    Wien Klin Wochenschr; 1981 Sep; 93(16):512-4. PubMed ID: 6272500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates.
    Hristov AC; Comfere NI; Vidal CI; Sundram U
    J Cutan Pathol; 2020 Nov; 47(11):1103-1110. PubMed ID: 32870521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement.
    Ritter JH; Wick MR; Adesokan PN; Fitzgibbon JF; Zhu X; Humphrey PA
    Am J Clin Pathol; 1997 Jul; 108(1):60-8. PubMed ID: 9208979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous lymphoplasmacytoid lymphoma (immunocytoma).
    van der Putte SC; de Kreek EJ; Go DM; van Unnik JA
    Am J Dermatopathol; 1984 Feb; 6(1):15-24. PubMed ID: 6422787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of immunoglobulin-bearing lymphoma cells by fixation.
    Warnke R
    J Histochem Cytochem; 1979 Aug; 27(8):1195-6. PubMed ID: 113452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1982 Jun; 49(11):2321-35. PubMed ID: 6804083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas.
    Burg G; Schmid MH; Küng E; Dommann S; Dummer R
    Dermatol Clin; 1994 Apr; 12(2):399-407. PubMed ID: 8045051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.
    Cerroni L; Signoretti S; Höfler G; Annessi G; Pütz B; Lackinger E; Metze D; Giannetti A; Kerl H
    Am J Surg Pathol; 1997 Nov; 21(11):1307-15. PubMed ID: 9351568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual patterns of immunoglobulin gene rearrangement and expression during human B cell ontogeny: human B cells can simultaneously express cell surface kappa and lambda light chains.
    Pauza ME; Rehmann JA; LeBien TW
    J Exp Med; 1993 Jul; 178(1):139-49. PubMed ID: 8391059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocytochemical characterization of lymphocytes in benign and malignant lymphocyte-rich serous effusions.
    Spieler P; Kradolfer D; Schmid U
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):211-21. PubMed ID: 3087054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.